ROIV Roivant Sciences Ltd
- Stocks
- Healthcare
- NASDAQ: ROIV
Price (delayed)
$11.85
Market cap
$8.09B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.7
Enterprise value
$6.95B
Highlights
The debt has dropped by 74% year-on-year
The company's quick ratio rose by 50% YoY and by 21% QoQ
The EPS has shrunk by 192% QoQ and by 112% YoY
The net income has dropped by 185% since the previous quarter and by 110% year-on-year
Key stats
What are the main financial stats of ROIV
Market
Valuations
Earnings
Shares outstanding
682.88M
Market cap
$8.09B
Enterprise value
$6.95B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.85
Price to sales (P/S)
346.98
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
299.29
Revenue
$23.23M
Gross profit
$22.38M
Operating income
-$1.19B
Net income
-$490.63M
EBIT
-$449.77M
EBITDA
-$432.28M
Free cash flow
-$858.67M
Per share
Balance sheet
Liquidity
EPS
-$0.7
EPS diluted
-$0.7
Free cash flow per share
-$1.26
Book value per share
$6.39
Revenue per share
$0.03
TBVPS
$7.4
Total assets
$5.03B
Total liabilities
$216.7M
Debt
$99.69M
Equity
$4.35B
Working capital
$4.5B
Debt to equity
0.02
Current ratio
40.54
Quick ratio
39.55
Net debt/EBITDA
2.63
Margins
Efficiency
Dividend
EBITDA margin
-1,860.6%
Gross margin
96.3%
Net margin
-2,111.8%
Operating margin
-5,104.7%
Return on assets
-8.7%
Return on equity
-10.1%
Return on invested capital
-12.9%
Return on capital employed
-9.1%
Return on sales
-1,935.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ROIV stock price
How has the Roivant Sciences stock price performed over time
Intraday
0.85%
1 week
3.13%
1 month
4.31%
1 year
4.77%
YTD
0.17%
QTD
5.15%
Financial performance
How have Roivant Sciences's revenue and profit performed over time
Revenue
$23.23M
Gross profit
$22.38M
Operating income
-$1.19B
Net income
-$490.63M
Gross margin
96.3%
Net margin
-2,111.8%
The net income has dropped by 185% since the previous quarter and by 110% year-on-year
ROIV's operating margin has dropped by 140% year-on-year and by 48% since the previous quarter
ROIV's operating income has dropped by 126% year-on-year and by 18% since the previous quarter
The net margin has dropped by 116% year-on-year
Price vs fundamentals
How does ROIV's price correlate with its fundamentals
Growth
What is Roivant Sciences's growth rate over time
Valuation
What is Roivant Sciences stock price valuation
P/E
N/A
P/B
1.85
P/S
346.98
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
299.29
The EPS has shrunk by 192% QoQ and by 112% YoY
The stock's price to book (P/B) is 78% less than its 5-year quarterly average of 8.4 but 8% more than its last 4 quarters average of 1.7
ROIV's equity is down by 20% year-on-year and by 7% since the previous quarter
The stock's price to sales (P/S) is 84% more than its 5-year quarterly average of 186.7 and 26% more than its last 4 quarters average of 272.8
Roivant Sciences's revenue has decreased by 36% YoY and by 20% QoQ
Efficiency
How efficient is Roivant Sciences business performance
ROIV's return on assets has dropped by 200% since the previous quarter and by 111% year-on-year
The ROE has shrunk by 197% QoQ and by 110% YoY
The ROIC has plunged by 187% from the previous quarter and by 102% YoY
The ROS has shrunk by 115% YoY
Dividends
What is ROIV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ROIV.
Financial health
How did Roivant Sciences financials performed over time
ROIV's total liabilities has dropped by 64% year-on-year and by 13% since the previous quarter
The company's quick ratio rose by 50% YoY and by 21% QoQ
The debt is 98% smaller than the equity
The debt has dropped by 74% year-on-year
The debt to equity has dropped by 71% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.